-
Lars Wallentin, Christoph Varenhorst, Stefan James, David Erlinge, Oscar Ö Braun, Joseph A. Jakubowski, Atsuhiro Sugidachi, Kenneth J. Winters, and Agneta Siegbahn
- Prasugrel achieves greater and faster P2Y12receptor-mediated platelet inhibition than clopidogrel due to more efficient generation of its active metabolite in aspirin-treated patients with coronary artery disease
European Heart Journal Advance Access published on November 30, 2007
Eur Heart J 2008 29: 21-30; doi:10.1093/eurheartj/ehm545
[Abstract]
[FREE Full Text]
[PDF]
OPEN ACCESS ARTICLE
|